This is the kind of change that flies under the radar and makes a big difference. This week, Novo Nordisk received FDA approval of a 2 mg dose of semaglutide (Ozempic®) for better control of type 2 diabetes. This higher dose option provides a means for maintaining better glycemic control in patients as their disease […]

